This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment of a medium sized pulmonary embolus

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Consult expert help:

  • sit the patient up (unless there is severe shock)
  • administer oxygen, up to 100%
  • administer morphine 10 mg i.v., especially if patient in pain
  • start heparin
    • low molecular weight heparin is as effective as unfractionated heparin (1)
  • give patient thrombo embolism deterrent stockings to wear
  • patients have and require high right heart filling pressures; treatment with diuretics and vasodilators is deleterious
  • once stabilised on heparin, commence warfarin treatment; give loading dose of 10 mg daily for two days; adjust third daily dose according to the patient's INR. Aim to maintain the INR at 2.5-3.5X normal. In general, treatment with warfarin is for 6 months for a first PE (1)


  1. Robinson GV. Pulmonary embolism in hospital practice. BMJ 2006; 332: 156-60.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.